Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

doi:10.1084/jem.166.4.1132

This Article

	Full Text (PDF, 351K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Maury, C. P.
	Articles by Teppo, A. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Maury, C. P.
	Articles by Teppo, A. M.


Social Bookmarking

	What's this?

ARTICLES

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

CP Maury and AM Teppo
Fourth Department of Medicine, University of Helsinki, Finland.

A sensitive radioimmunoassay was used for monitoring serum levels of endogenous cachectin/tumor necrosis factor alpha (TNF) in 10 renal transplant recipients. Acute allograft rejections were associated with marked elevations of circulating TNF. The peak levels of TNF (median 140 pg/ml) were in the same concentration range as previously reported in parasitic infections. The results show that the release of TNF into circulation is an early event in renal allograft rejection and that raised levels of TNF in man can also be induced by noninfectious stimuli.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Sethu, S., Mendez-Corao, G., Melendez, A. J. (2008). Phospholipase D1 Plays a Key Role in TNF-{alpha} Signaling. J. Immunol. 180: 6027-6034 [Abstract] [Full Text]
Azzawi, M., Hasleton, P. (1999). Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease. Cardiovasc Res 43: 850-859 [Full Text]
Aarnio, P., Schersten, H., Tazelaar, H. D., Miller, V. M., McGregor, C. G. A. (1996). EFFECTS OF ACUTE REJECTION AND ANTIREJECTION THERAPY ON ARTERIES AND VEINS FROM CANINE SINGLE LUNG ALLOGRAFTS. J. Thorac. Cardiovasc. Surg. 111: 1219-1229 [Abstract] [Full Text]
Worrall, N. K., Chang, K., Suau, G. M., Allison, W. S., Misko, T. P., Sullivan, P. M., Tilton, R. G., Williamson, J. R., Ferguson, T. B. Jr (1996). Inhibition of Inducible Nitric Oxide Synthase Prevents Myocardial and Systemic Vascular Barrier Dysfunction During Early Cardiac Allograft Rejection. Circ. Res. 78: 769-779 [Abstract] [Full Text]
Amouzadeh, H. R., Qualls, C. W. Jr, Wyckoff, J. H. III, Dzata, G. K., Sangiah, S., Mauromoustakos, A., Stein, L. E. (1993). Biochemical and Morphological Alterations in Xylazine-Induced Pulmonary Edema*,{dagger}. Toxicol Pathol 21: 562-571 [Abstract]
Basaran, Y., Basaran, M.M., Babacan, K.F., Ener, B., Okay, T., Gok, H., Ozdemir, M. (1993). Serum Tumor Necrosis Factor Levels in Acute Myocardial Infarction and Unstable Angina Pectoris. ANGIOLOGY 44: 332-337 [Abstract]
Yuman Fong, , Lowry, S. F., Cerami, A. (1988). Cachectin/TNF: A Macrophage Protein That Induces Cachexia and Shock. JPEN J Parenter Enteral Nutr 12: 72S-77S [Abstract]